Mechanisms of dihydromyricetin against hepatocellular carcinoma elucidated by network pharmacology combined with experimental validation

Author:

Zhang Shuo1,Shi Ya-Ning12,Gu Jia1,He Peng1,Ai Qi-Di1,Zhou Xu-Dong3,Wang Wei3,Qin Li14

Affiliation:

1. Laboratory of Stem Cell Regulation with Chinese Medicine and Its Application, School of Pharmacy, Hunan University of Chinese Medicine, Changsha, China

2. Science and Technology Innovation Center, Hunan University of Chinese Medicine, Changsha, China

3. TCM and Ethnomedicine Innovation & Development International Laboratory, Innovative Material Medical Research Institute, School of Pharmacy, Hunan University of Chinese Medicine, Changsha, China

4. Institutional Key Laboratory of Vascular Biology and Translational Medicine in Hunan Province, Hunan University of Chinese Medicine, Changsha, China

Funder

the National Natural Sciences Foundation of China

National Science Fund of Hunan Province

the Key Project of the Educational Department of Hunan Province

Open Fund of the State Key Laboratory Cultivation Base Co-constructed by the Ministry of Traditional Chinese Medicine Powder and Innovative Drug Research in Hunan Province

the Scientific Research Project of Changsha Science and Technology Bureau

Key Project of Hunan Provincial Health Commission

Pharmaceutical Open Fund of Domestic First-class Disciplines (cultivation) of Hunan Province

the Graduate Research innovation project of Hunan University of Chinese Medicine

the innovation project of university students in Hunan University of Chinese Medicine

Hunan College Students Innovation and Entrepreneurship Training Program Support Project

the Youth Project of Natural Science Foundation of Hunan Province

the Youth Project of Educational Department of Hunan Province

the Special Scientific and Technological Project for the Comprehensive Utilization of Ampelopsis grossedentata Resources of Hunan Qiankun Biotechnology Co., Ltd.

the First-Class Discipline of Pharmaceutical Science of Hunan

Publisher

Informa UK Limited

Subject

Complementary and alternative medicine,Drug Discovery,Pharmaceutical Science,Pharmacology,Molecular Medicine,General Medicine

Cited by 3 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3